Further tumor microenvironment investigations based on a subcutaneous liver cancer mouse model identified that 125I therapy recruited Cd274/Pd‐l1+ neutrophils and induced T‐cell exhaustion, leading to immune evasion and brachytherapy resistance. The gene discussed is CD274; the disease is neoplasm.